Abstract
One hundred and fifteen patients suffering from acute exacerbations of chronic bronchitis took part in a double-blind, multicentre, clinical trial designed to compare the therapeutic efficacy and tolerability of ampicillin and minocycline hydrochloride, a new, long-acting, semi-synthetic tetracycline.
Both antibiotics were equally successful in treatment, there being no statistically significant difference between the two in any of the parameters studied.
Side-effects were few and far between. Only one patient out of the 57 who took minocycline, complained of dizziness.
Get full access to this article
View all access options for this article.
